Qinghai Spring Medicinal Resources Technology Co., Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 128.65 million compared to CNY 81.48 million a year ago. Revenue was CNY 128.65 million compared to CNY 81.48 million a year ago.

Net loss was CNY 75.4 million compared to CNY 60 million a year ago. Basic loss per share from continuing operations was CNY 0.128 compared to CNY 0.102 a year ago. Diluted loss per share from continuing operations was CNY 0.128 compared to CNY 0.102 a year ago.